Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Cathomas

Showing results (11-20 of 139) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 12, 2014
Measurement or estimation of glomerular filtration rate in seminoma patients: quite another cup of teaMartin Fehr, Tom Geldart, Dirk Klingbiel, et al.
Hematology/Oncology Clinics of North America|April 4, 2015
First-line treatment of metastatic disease: cisplatin-ineligible patientsRichard Cathomas, Maria De Santis, Matthew D Galsky
Breast Care (Basel, Switzerland)|November 1, 2021
A Rare Case of Breast Malignancy in an Adolescent Woman: Lessons Learned from Diagnosis and ManagementCélina Alexandra Fehr, Philip Went, Martina Maranta, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Intratumoral therapy with interferon-alpha in a locoregional advanced malignant blue nevus: a brief communicationRoger von Moos, Reto Schaffner, Richard Cathomas, et al.
European Urology|May 12, 2024
Re: Detection of Recurrence Through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 StudyChristian D Fankhauser, Richard Cathomas, Silke Gillessen, et al.
Onkologie|October 8, 2010
Spontaneous pneumothorax during chemotherapy: a case reportMartin Fehr, Roger von Moos, Markus Furrer, et al.
Lung Cancer (Amsterdam, Netherlands)|July 22, 2016
Combination of cisplatin and lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma: Report of two casesYannis Metaxas, Richard Cathomas, Michael Mark, et al.
ESMO Open|March 14, 2018
Carboplatin dose based on actual renal function: no excess of acute haematotoxicity in adjuvant treatment in seminoma stage IMartin Fehr, Angela Fischer Maranta, Hermann Reichegger, et al.
Research and Reports in Urology|October 6, 2022
Treatment Landscape for Patients with Castration-Resistant Prostate Cancer: Patient Selection and Unmet Clinical NeedsFabio Turco, Silke Gillessen, Richard Cathomas, et al.
Journal of the National Cancer Institute|December 1, 2021
RE: Real-World Use of Bone Modifying Agents in Metastatic Castration-Sensitive Prostate CancerMichael Mark, Roger von Moos, Richard Cathomas, et al.
Pageof 14

Showing results (11-20 of 139) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|June 12, 2014
Measurement or estimation of glomerular filtration rate in seminoma patients: quite another cup of teaMartin Fehr, Tom Geldart, Dirk Klingbiel, et al.
Hematology/Oncology Clinics of North America|April 4, 2015
First-line treatment of metastatic disease: cisplatin-ineligible patientsRichard Cathomas, Maria De Santis, Matthew D Galsky
Breast Care (Basel, Switzerland)|November 1, 2021
A Rare Case of Breast Malignancy in an Adolescent Woman: Lessons Learned from Diagnosis and ManagementCélina Alexandra Fehr, Philip Went, Martina Maranta, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Intratumoral therapy with interferon-alpha in a locoregional advanced malignant blue nevus: a brief communicationRoger von Moos, Reto Schaffner, Richard Cathomas, et al.
European Urology|May 12, 2024
Re: Detection of Recurrence Through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 StudyChristian D Fankhauser, Richard Cathomas, Silke Gillessen, et al.
Onkologie|October 8, 2010
Spontaneous pneumothorax during chemotherapy: a case reportMartin Fehr, Roger von Moos, Markus Furrer, et al.
Lung Cancer (Amsterdam, Netherlands)|July 22, 2016
Combination of cisplatin and lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma: Report of two casesYannis Metaxas, Richard Cathomas, Michael Mark, et al.
ESMO Open|March 14, 2018
Carboplatin dose based on actual renal function: no excess of acute haematotoxicity in adjuvant treatment in seminoma stage IMartin Fehr, Angela Fischer Maranta, Hermann Reichegger, et al.
Research and Reports in Urology|October 6, 2022
Treatment Landscape for Patients with Castration-Resistant Prostate Cancer: Patient Selection and Unmet Clinical NeedsFabio Turco, Silke Gillessen, Richard Cathomas, et al.
Journal of the National Cancer Institute|December 1, 2021
RE: Real-World Use of Bone Modifying Agents in Metastatic Castration-Sensitive Prostate CancerMichael Mark, Roger von Moos, Richard Cathomas, et al.
Pageof 14